Clinical and Biological Efficacy of Recombinant Human Interleukin-21 in Patients With Stage IV Malignant Melanoma Without Prior Treatment: A Phase IIa Trial
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-08-2663
Full Text
Open PDFAbstract
Available in full text
Date
March 10, 2009
Authors
Publisher
American Association for Cancer Research (AACR)